Incidental Mutation 'IGL00485:Brms1'
ID |
5696 |
Institutional Source |
Australian Phenomics Network
(link to record)
|
Gene Symbol |
Brms1
|
Ensembl Gene |
ENSMUSG00000080268 |
Gene Name |
breast cancer metastasis-suppressor 1 |
Synonyms |
|
Accession Numbers |
|
Essential gene? |
Probably essential
(E-score: 0.848)
|
Stock # |
IGL00485
|
Quality Score |
|
Status
|
|
Chromosome |
19 |
Chromosomal Location |
5091391-5099940 bp(+) (GRCm39) |
Type of Mutation |
unclassified |
DNA Base Change (assembly) |
A to C
at 5099070 bp (GRCm39)
|
Zygosity |
Heterozygous |
Amino Acid Change |
|
Ref Sequence |
ENSEMBL: ENSMUSP00000153574
(fasta)
|
Gene Model |
predicted gene model for transcript(s):
[ENSMUST00000025818]
[ENSMUST00000116567]
[ENSMUST00000224178]
[ENSMUST00000224288]
[ENSMUST00000224363]
[ENSMUST00000225799]
[ENSMUST00000225427]
|
AlphaFold |
Q99N20 |
Predicted Effect |
probably benign
Transcript: ENSMUST00000025818
|
SMART Domains |
Protein: ENSMUSP00000025818 Gene: ENSMUSG00000024883
Domain | Start | End | E-Value | Type |
SH2
|
66 |
153 |
2.16e-5 |
SMART |
low complexity region
|
241 |
264 |
N/A |
INTRINSIC |
low complexity region
|
286 |
300 |
N/A |
INTRINSIC |
low complexity region
|
307 |
341 |
N/A |
INTRINSIC |
low complexity region
|
405 |
422 |
N/A |
INTRINSIC |
low complexity region
|
432 |
454 |
N/A |
INTRINSIC |
VPS9
|
478 |
596 |
2.29e-64 |
SMART |
RA
|
613 |
694 |
1.14e-12 |
SMART |
|
Predicted Effect |
probably benign
Transcript: ENSMUST00000116567
|
SMART Domains |
Protein: ENSMUSP00000112266 Gene: ENSMUSG00000080268
Domain | Start | End | E-Value | Type |
low complexity region
|
29 |
59 |
N/A |
INTRINSIC |
Pfam:Sds3
|
60 |
209 |
5.3e-23 |
PFAM |
|
Predicted Effect |
probably benign
Transcript: ENSMUST00000224032
|
Predicted Effect |
probably benign
Transcript: ENSMUST00000224178
|
Predicted Effect |
noncoding transcript
Transcript: ENSMUST00000224254
|
Predicted Effect |
probably benign
Transcript: ENSMUST00000224288
|
Predicted Effect |
probably benign
Transcript: ENSMUST00000224363
|
Predicted Effect |
probably benign
Transcript: ENSMUST00000225799
|
Predicted Effect |
noncoding transcript
Transcript: ENSMUST00000225203
|
Predicted Effect |
probably benign
Transcript: ENSMUST00000225427
|
Coding Region Coverage |
|
Validation Efficiency |
|
MGI Phenotype |
FUNCTION: [Summary is not available for the mouse gene. This summary is for the human ortholog.] This gene reduces the metastatic potential, but not the tumorogenicity, of human breast cancer and melanoma cell lines. The protein encoded by this gene localizes primarily to the nucleus and is a component of the mSin3a family of histone deacetylase complexes (HDAC). The protein contains two coiled-coil motifs and several imperfect leucine zipper motifs. Alternative splicing results in two transcript variants encoding different isoforms. [provided by RefSeq, Jul 2008]
|
Allele List at MGI |
All alleles(12) : Targeted(2) Gene trapped(10)
|
Other mutations in this stock |
Total: 26 list
Gene | Ref | Var | Chr/Loc | Mutation | Predicted Effect | Zygosity |
Arhgap23 |
G |
A |
11: 97,383,497 (GRCm39) |
|
probably benign |
Het |
Arhgef37 |
G |
A |
18: 61,656,942 (GRCm39) |
T41I |
probably damaging |
Het |
Cdkn1a |
C |
A |
17: 29,317,494 (GRCm39) |
A38E |
possibly damaging |
Het |
Col4a2 |
A |
G |
8: 11,489,012 (GRCm39) |
M1133V |
probably benign |
Het |
Ctps1 |
T |
C |
4: 120,410,141 (GRCm39) |
Y314C |
probably damaging |
Het |
Defa30 |
T |
A |
8: 21,625,467 (GRCm39) |
M77K |
probably benign |
Het |
Eif3a |
T |
C |
19: 60,758,328 (GRCm39) |
R817G |
unknown |
Het |
Entrep1 |
G |
A |
19: 23,962,086 (GRCm39) |
R306W |
probably damaging |
Het |
Ftdc2 |
A |
G |
16: 58,455,854 (GRCm39) |
Y140H |
probably damaging |
Het |
Greb1l |
A |
G |
18: 10,555,962 (GRCm39) |
S1725G |
possibly damaging |
Het |
Hmgxb4 |
T |
C |
8: 75,756,131 (GRCm39) |
S545P |
probably damaging |
Het |
Hrob |
C |
T |
11: 102,146,783 (GRCm39) |
S353F |
possibly damaging |
Het |
Kif13b |
A |
G |
14: 65,002,522 (GRCm39) |
E1049G |
possibly damaging |
Het |
Mug1 |
T |
C |
6: 121,864,375 (GRCm39) |
V1424A |
probably benign |
Het |
Nlrp2 |
A |
G |
7: 5,340,547 (GRCm39) |
V89A |
probably benign |
Het |
Osbpl11 |
T |
G |
16: 33,062,115 (GRCm39) |
W741G |
probably damaging |
Het |
Pam |
A |
G |
1: 97,750,678 (GRCm39) |
V914A |
possibly damaging |
Het |
Phldb2 |
T |
A |
16: 45,577,551 (GRCm39) |
I1117F |
possibly damaging |
Het |
Pign |
A |
T |
1: 105,525,448 (GRCm39) |
L460* |
probably null |
Het |
Pramel31 |
G |
A |
4: 144,090,012 (GRCm39) |
V351I |
probably damaging |
Het |
Prdm10 |
A |
T |
9: 31,238,842 (GRCm39) |
I196F |
possibly damaging |
Het |
Stk36 |
T |
C |
1: 74,673,244 (GRCm39) |
S1044P |
probably benign |
Het |
Trim43b |
T |
C |
9: 88,973,695 (GRCm39) |
T13A |
probably benign |
Het |
Unc5b |
T |
C |
10: 60,618,995 (GRCm39) |
Y49C |
possibly damaging |
Het |
Urb2 |
T |
C |
8: 124,755,433 (GRCm39) |
I380T |
probably damaging |
Het |
Zfyve27 |
T |
A |
19: 42,171,872 (GRCm39) |
C229S |
probably benign |
Het |
|
Other mutations in Brms1 |
Allele | Source | Chr | Coord | Type | Predicted Effect | PPH Score |
IGL01391:Brms1
|
APN |
19 |
5,096,723 (GRCm39) |
missense |
possibly damaging |
0.79 |
IGL02583:Brms1
|
APN |
19 |
5,096,206 (GRCm39) |
missense |
probably damaging |
0.99 |
PIT4576001:Brms1
|
UTSW |
19 |
5,096,229 (GRCm39) |
missense |
probably damaging |
1.00 |
R0054:Brms1
|
UTSW |
19 |
5,096,727 (GRCm39) |
nonsense |
probably null |
|
R0054:Brms1
|
UTSW |
19 |
5,096,727 (GRCm39) |
nonsense |
probably null |
|
R0670:Brms1
|
UTSW |
19 |
5,095,999 (GRCm39) |
missense |
probably damaging |
1.00 |
R1757:Brms1
|
UTSW |
19 |
5,096,435 (GRCm39) |
missense |
probably damaging |
1.00 |
R1962:Brms1
|
UTSW |
19 |
5,096,027 (GRCm39) |
missense |
probably damaging |
0.97 |
R6963:Brms1
|
UTSW |
19 |
5,096,681 (GRCm39) |
missense |
probably damaging |
1.00 |
R7096:Brms1
|
UTSW |
19 |
5,096,708 (GRCm39) |
missense |
probably damaging |
1.00 |
R8241:Brms1
|
UTSW |
19 |
5,096,007 (GRCm39) |
missense |
probably benign |
0.00 |
R8444:Brms1
|
UTSW |
19 |
5,091,520 (GRCm39) |
critical splice donor site |
probably null |
|
|
Posted On |
2012-04-20 |